Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
Ann Ig ; 33(5): 401-409, 2021.
Article in English | MEDLINE | ID: mdl-33270079

ABSTRACT

Conclusions: Our data reinforces the need to monitor the molecular epidemiology of CR A. baumannii and its associated antimicrobial resistance genes at national level. Background: Carbapenem-resistant (CR) Acinetobacter baumannii has been increasingly recognized as a major cause of health care-associated infections in critically ill patients and hospital outbreaks. Results: CR A. baumannii isolates assigned to international clonal lineage II (ICL II) and to ST78 clonal lineages were responsible for several epidemics in Italian hospitals during 2002-2018. Molecular analysis of carbapenem resistance showed the presence of OXA-58 CHDL in A. baumannii isolates assigned to ICL II and ST78 clonal lineage, which was replaced by OXA-23 CHDL in A. baumannii isolates assigned to ICL II since 2007 in several hospitals. CR A. baumannii was mainly responsible for respiratory tract infections and at a lesser extent for sepsis in intensive care unit patients. Methods: A narrative review of literature was conducted, searching PubMed database for articles on CR Acinetobacter spp. isolates from Italy published between January 2010 and December 2019.


Subject(s)
Acinetobacter Infections , Acinetobacter baumannii , Acinetobacter Infections/drug therapy , Acinetobacter Infections/epidemiology , Acinetobacter baumannii/genetics , Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Humans , Italy/epidemiology , Microbial Sensitivity Tests , Molecular Epidemiology , beta-Lactamases
2.
Ann Ig ; 30(5 Supple 2): 64-69, 2018.
Article in English | MEDLINE | ID: mdl-30374512

ABSTRACT

BACKGROUND: In 2014, the Italian Study Group of Hospital Hygiene of the Italian Society of Hygiene, Preventive Medicine and Public Health (GISIO-SItI), in collaboration with the National Association of Medical Hospital Managers (ANMDO), conducted a survey on the availability of procedures for cleaning and disinfecting ambulances in order to assess the practices in use. METHODS: An online questionnaire was prepared through the Survey Monkey® platform and a web link access was sent to a convenience sample of ANMDO doctors working in healthcare management in public and private healthcare facilities. RESULTS: Ninety-six questionnaires were collected (26% response rate). In 73% of cases there was a procedure for cleaning and disinfecting ambulances, which had been produced at a company level (67%) and involved various professionals. In 21% of cases the procedure had been prepared in expectation of an epidemic or following an epidemic (5%). The recommendations had been presented to the staff (90%), in 28% of cases through training events with verification of the knowledge acquired. Monitoring of the implementation of the procedure is planned in the majority of cases (88%), mainly through direct observation (92%). In 67% of cases the tender specifications for ambulance services did not include a section dedicated to cleaning and disinfection and, in the absence of a procedure, this was provided by the hospital in only 51% of case. CONCLUSION: This survey represented a first step towards the development of guidelines for standardising procedures and providing indications useful for their evaluation and monitoring their implementation.


Subject(s)
Ambulances/standards , Disinfection/standards , Guidelines as Topic/standards , Household Work/standards , Disinfection/methods , Equipment Contamination/prevention & control , Humans , Hygiene , Italy , Societies, Medical , Surveys and Questionnaires/statistics & numerical data
3.
Ann Ig ; 30(5 Supple 2): 7-14, 2018.
Article in English | MEDLINE | ID: mdl-30374507

ABSTRACT

BACKGROUND: In Italy there are no rules concerning the establishment of a hospital hygiene structure in hospitals and other healthcare settings, and the hospital organization plans vary widely. The aim of the survey, carried out by the Italian Study Group of Hospital Hygiene of the Italian Society of Hygiene, Preventive medicine and Public health, was to evaluate the presence in the hospital organization plan of a structure referred to as Hospital hygiene, or including in its denomination the words "hygiene" or "hospital hygiene", the activities carried out, the relation to other areas, like patient safety, the type and quantity of professionals involved, the strengths and the critical aspects. METHODS: A semi-structured questionnaire was administered to Healthcare Trusts representing all Italian Regions through the members of the above Study Group. RESULTS: 35 Trusts, 13 in Northern, 8 in Central, 14 in Southern Italy (including Sicily and Sardinia), completed the questionnaire. In 19 Trusts (54.3%) a structure whose denomination included the words "hospital hygiene" or "hygiene" was present. The activities related to the management of infectious risk were most represented, carried out autonomously or in collaboration, but many other activities were covered. In all hospitals the activities of the Hospital Hygiene Unit inter-linked with those of the clinical risk, with different forms of collaboration. CONCLUSION: This survey, even though on a limited sample, provided a picture of hospital hygiene at a national level, showing a considerable heterogeneity and highlighting critical issues but also strengths. It is essential to share organizational and management models that enhance and promote hospital hygiene, to ensure the appropriateness of healthcare practices offered in a safe and comfortable environment to patients, operators, and visitors.


Subject(s)
Cross Infection/prevention & control , Hospital Administration , Hygiene , Infection Control/organization & administration , Surveys and Questionnaires , Hospitals , Humans , Italy , Societies, Medical , Surveys and Questionnaires/statistics & numerical data
4.
Ann Ig ; 29(6): 529-547, 2017.
Article in English | MEDLINE | ID: mdl-29048451

ABSTRACT

BACKGROUND: Healthcare-associated infections (HAIs) are an important issue in terms of quality of care. HAIs impact patient safety by contributing to higher rates of preventable mortality and prolonged hospitalizations. In Italy, analysis of the currently available accreditation systems shows a substantial heterogeneity of approaches for the prevention and surveillance of HAIs in hospitals. The aim of the present study is to develop and propose the use of a synthetic assessment tool that could be implemented homogenously throughout the nation. METHODS: An analysis of nine international and of the 21 Italian regional accreditation systems was conducted in order to identify requirements and indicators implemented for HAI prevention and control. Two relevant reviews on this topic were further analyzed to identify additional evidence-based criteria. The project team evaluated all the requirements and indicators with consensus meeting methodology, then those applicable to the Italian context were grouped into a set of "focus areas". RESULTS: The analysis of international systems and Italian regional accreditation manuals led to the identification respectively of 19 and 14 main requirements, with relevant heterogeneity in their application. Additional evidence-based criteria were included from the reviews analysis. From the consensus among the project team members all the standards were compared and 20 different thematic areas were identified, with a total of 96 requirements and indicators for preventing and monitoring HAIs. CONCLUSIONS: The study reveals a great heterogeneity in the definition of accreditation criteria between the Italian regions. The introduction of a uniform, synthetic assessment instrument, based on the review of national and international standards, may serve as a self-assessment tool to evaluate the achievement of a minimum standards set for HAIs prevention and control in healthcare facilities. This may be used as an assessment tool by the Italian institutional accreditation system, also useful to reduce regional disparities.


Subject(s)
Accreditation , Cross Infection/prevention & control , Hospitals/standards , Process Assessment, Health Care , Humans , Italy
5.
J Hosp Infect ; 82(4): 260-5, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23102814

ABSTRACT

AIM: To report an outbreak of extensively drug-resistant (XDR) Acinetobacter baumannii in the neonatal intensive care unit (NICU) of an Italian university hospital. Patient risk profiles for acquisition of A. baumannii and measures used to control the outbreak are described. METHODS: Antibiotic susceptibility of strains was evaluated by microdilution. Genotyping was performed by pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing. Carbapenemase genes were analysed by polymerase chain reaction and DNA sequencing. A case-control study was designed to identify risk factors for acquisition of A. baumannii. FINDINGS: A. baumannii was isolated from 22 neonates, six of whom were infected. One major PFGE type was identified, assigned to sequence type (ST) 2, corresponding to International Clone II; this was indistinguishable from isolates from the adult ICU in the same hospital. A. baumannii isolates were resistant to aminoglycosides, quinolones and classes of ß-lactam antibiotics, but were susceptible to tigecycline and colistin. Carbapenem resistance was associated with the presence of transposon Tn2006 carrying the bla(OxA-23) gene. Length of NICU stay, length of exposure to A. baumannii, gestational age, use of invasive devices and length of exposure to invasive devices were significantly associated with acquisition of A. baumannii on univariate analysis, while length of exposure to central venous catheters and assisted ventilation were the only independent risk factors after multi-variate analysis. CONCLUSIONS: This XDR A. baumannii outbreak in an NICU was probably caused by intrahospital transfer of bacteria via a colonized neonate whose mother was admitted to the adult ICU. Strengthened infection control measures were necessary to control the outbreak.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter Infections/transmission , Acinetobacter baumannii/classification , Drug Resistance, Multiple, Bacterial , Intensive Care, Neonatal , Molecular Typing , Acinetobacter Infections/microbiology , Acinetobacter baumannii/genetics , Acinetobacter baumannii/isolation & purification , Adult , Case-Control Studies , Electrophoresis, Gel, Pulsed-Field , Female , Humans , Infant, Newborn , Infection Control/methods , Italy/epidemiology , Male , Molecular Epidemiology , Risk Factors
6.
Clin Microbiol Infect ; 17(2): 197-201, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20456455

ABSTRACT

Thirty-five multidrug-resistant Acinetobacter baumannii strains, representative of 28 outbreaks involving 484 patients from 20 hospitals in Greece, Italy, Lebanon and Turkey from 1999 to 2009, were analysed by multilocus sequence typing. Sequence type (ST)2, ST1, ST25, ST78 and ST20 caused 12, four, three, three and two outbreaks involving 227, 93, 62, 62 and 31 patients, respectively. The genes bla(oxa-58), bla(oxa-23) and bla(oxa-72) were found in 27, two and one carbapenem-resistant strain, respectively. In conclusion, A. baumannii outbreaks were caused by the spread of a few strains.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter baumannii/classification , Acinetobacter baumannii/drug effects , Bacterial Typing Techniques , Cross Infection/epidemiology , Drug Resistance, Multiple, Bacterial , Multilocus Sequence Typing , Acinetobacter Infections/microbiology , Acinetobacter baumannii/genetics , Acinetobacter baumannii/isolation & purification , Cluster Analysis , Cross Infection/microbiology , Disease Outbreaks , Genotype , Humans , Mediterranean Region/epidemiology , Molecular Epidemiology , beta-Lactamases/genetics
7.
J Hosp Infect ; 67(2): 135-41, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17884248

ABSTRACT

We investigated the molecular epidemiology of gentamicin-resistant, extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae and Serratia marcescens, and risk factors associated with their acquisition in a neonatal intensive care unit (NICU) of a university hospital in Italy. During the study period (April-November 2004), S. marcescens was responsible for six infections and 31 colonisations, while K. pneumoniae was responsible for six infections and 103 colonisations. Concurrent isolation of both organisms occurred in 24 neonates. Molecular typing identified one major pulsed-field gel electrophoresis pattern each for S. marcescens and K. pneumoniae strains isolated during the study period. An 80 kb plasmid containing bla(SHV-12), bla(TEM-1) and aac(6')-Ib genes, isolated from both S. marcescens and K. pneumoniae strains, and showing identical restriction profiles, transferred resistance to third-generation cephalosporins to a previously susceptible Escherichia coli host. Birthweight, gestational age and use of invasive devices were significantly associated with S. marcescens and K. pneumoniae acquisition on univariate analysis, while empiric antimicrobial treatment with ampicillin and gentamicin, and duration of hospital stay, proved to be the only independent risk factors. In conclusion, conjugal plasmid transfer and empiric antimicrobial therapy with ampicillin and gentamicin might have contributed to the selection and spread of gentamicin-resistant ESBL-producing Enterobacteriaceae in the NICU.


Subject(s)
Klebsiella Infections/microbiology , Klebsiella pneumoniae/enzymology , Serratia Infections/microbiology , Serratia marcescens/enzymology , beta-Lactamases/genetics , Acetyltransferases/genetics , Ampicillin/therapeutic use , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacterial Typing Techniques , Birth Weight , Carrier State/microbiology , Cephalosporins/pharmacology , DNA Fingerprinting , DNA, Bacterial/genetics , Drug Resistance, Bacterial , Electrophoresis, Gel, Pulsed-Field , Genotype , Gentamicins/pharmacology , Gestational Age , Humans , Infant , Infant, Newborn , Intensive Care Units, Neonatal , Italy , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/classification , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/isolation & purification , Molecular Epidemiology , Molecular Sequence Data , Plasmids/genetics , Risk Factors , Sequence Analysis, DNA , Serratia Infections/epidemiology , Serratia marcescens/classification , Serratia marcescens/drug effects , Serratia marcescens/isolation & purification , Surgical Procedures, Operative
8.
Clin Microbiol Infect ; 13(5): 481-9, 2007 May.
Article in English | MEDLINE | ID: mdl-17430339

ABSTRACT

This study investigated the molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii that occurred between June 2003 and June 2004 in a tertiary-care hospital in Naples, Italy. A. baumannii was isolated from 74 patients, of whom 38 were infected and 36 were colonised. Thirty-three patients had ventilator-associated pneumonia, three had hospital-acquired pneumonia, and two had sepsis. Genotypic analysis of 45 available A. baumannii isolates revealed two distinct pulsed-field gel electrophoresis (PFGE) patterns. Of these, PFGE pattern 1 was represented by isolates from 44 patients and was identical to that of an epidemic A. baumannii clone isolated in another hospital of Naples during 2002. All A. baumannii isolates of PFGE type 1 showed identical multiresistant antibiotypes, characterised by resistance to all antimicrobial agents tested, including carbapenems, with the exception of colistin. In these isolates, inhibition of OXA enzymes by 200 mM NaCl reduced the imipenem MIC by up to four-fold. Molecular analysis of antimicrobial resistance genes showed that all A. baumannii isolates of PFGE type 1 harboured a class 1 integron containing the aacA4, orfX and bla(OXA-20) gene cassettes, an ampC gene and a bla(OXA-51)-like allele. Moreover, a bla(OXA-58)-like gene surrounded by the regulatory elements ISAba2 and ISAba3 was identified in a 30-kb plasmid from A. baumannii isolates of PFGE type 1, but not PFGE type 2. Thus, selection of a single A. baumannii clone producing an OXA-58-type carbapenem-hydrolysing oxacillinase was responsible for the increase in the number of A. baumannii infections that occurred in this hospital.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter baumannii/genetics , Carbapenems/pharmacology , Cross Infection/microbiology , Disease Outbreaks , beta-Lactamases/genetics , Acinetobacter Infections/drug therapy , Acinetobacter Infections/genetics , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/pathogenicity , Aged , Community-Acquired Infections/drug therapy , Community-Acquired Infections/genetics , Community-Acquired Infections/microbiology , Cross Infection/mortality , Drug Resistance, Multiple, Bacterial , Electrophoresis, Gel, Pulsed-Field , Female , Hospitals, University , Humans , Intensive Care Units , Italy/epidemiology , Male , Microbial Sensitivity Tests , beta-Lactamases/classification
9.
Clin Microbiol Infect ; 12(3): 241-7, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16451411

ABSTRACT

The epidemiological impact of Acinetobacter baumannii nosocomial infections in a Sicilian intensive care unit (ICU) was investigated to determine the Acinetobacter-specific infection rates, to estimate the preventable proportion of Acinetobacter infections, i.e., those resulting from cross-transmission, and to investigate the molecular epidemiology of antimicrobial resistance in Acinetobacter. The impact of Acinetobacter nosocomial infection in the ICU was determined to be 3.0 new cases per 100 admissions. Site-specific rates confirmed that ICU-acquired pneumonia was the most important infection type. The incidence rate, adjusted by the number of patient-days, was 3.3 infections/1000 patient-days. The estimated preventable proportion of A. baumannii nosocomial infections in the ICU was 66.7%. A class 1 integron, characterised by its gene cassette content, was present in all A. baumannii isolates of four different pulsed-field gel electrophoresis types, and was associated significantly with clones implicated in cross-transmission episodes. Furthermore, the same integron was detected in two genetically distinct isolates responsible for recurrent infection in the same patient, suggesting the occurrence of horizontal gene transfer in vivo. Even in an endemic setting with low infection rates, spread of A. baumannii was caused mainly by infection control shortcomings that require appropriate surveillance and control policies.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter baumannii/genetics , Cross Infection/epidemiology , Intensive Care Units , Acinetobacter baumannii/drug effects , Anti-Bacterial Agents/pharmacology , Drug Resistance, Microbial , Electrophoresis, Gel, Pulsed-Field , Gene Transfer, Horizontal , Humans , Imipenem/pharmacology , Integrons/genetics , Italy/epidemiology , Meropenem , Morbidity , Pneumonia, Bacterial/epidemiology , Thienamycins/pharmacology
10.
J Hosp Infect ; 62(4): 494-501, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16455159

ABSTRACT

The molecular epidemiology of Legionella pneumophila in the 'V. Monaldi' University Hospital was studied. Seven cases of nosocomial Legionnaires' disease were diagnosed between 1999 and 2003. Two clinical legionella strains obtained from two patients in the adult cardiac surgery unit (CSU) and 30 environmental legionella strains from the paediatric and adult CSUs, neonatal intensive care unit (NICU) and the cardiorespiratory intensive care unit (CR-ICU) were serotyped and genotyped. L. pneumophila serogroup 1/Philadelphia with an identical pulsed-field gel electrophoresis (PFGE) profile A was isolated from two patients in the adult CSU, and from three and one water samples taken in the adult CSU and the paediatric CSU, respectively, from 2001 to 2002. Furthermore, L. pneumophila serogroup 3 with an identical PFGE profile B was identified in 20 environmental strains from all wards, L. pneumophila serogroup 3 with PFGE profile C was identified in a single environmental strain from the CR-ICU, and non-pneumophila Legionella with identical PFGE profile D was identified in five environmental strains from the adult CSU, paediatric CSU and NICU. Ultraviolet irradiation was effective in disinfection of the hospital water supplies in the adult and paediatric CSUs contaminated by L. pneumophila clone associated with nosocomial Legionnaires' disease. In conclusion, these data demonstrate that two cases of nosocomial legionellosis were caused by the persistence of a single clone of L. pneumophila serogroup 1/Philadelphia in the hospital environment, and that disinfection by ultraviolet irradiation may represent an effective measure to prevent nosocomial Legionnaires' disease.


Subject(s)
Cross Infection/microbiology , Infection Control/methods , Legionella pneumophila/isolation & purification , Legionnaires' Disease/microbiology , Cross Infection/transmission , Electrophoresis, Gel, Pulsed-Field , Hospitals, University , Humans , Intensive Care Units , Italy , Legionella pneumophila/classification , Legionella pneumophila/genetics , Legionnaires' Disease/transmission , Molecular Epidemiology , Serotyping , Ultraviolet Rays , Water Supply
11.
Clin Microbiol Infect ; 11(10): 814-9, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16153255

ABSTRACT

Streptococcus bovis is being recognised increasingly as a cause of infective endocarditis, and has also been associated with underlying gastrointestinal malignancy. This study evaluated the molecular epidemiology of S. bovis isolates responsible for endocarditis or bacteraemia in Italian patients between January 1990 and August 2003. S. bovis isolates were classified on the basis of their biochemical profiles, antimicrobial susceptibilities and genotypes. Of 25 isolates studied, 20 were S. bovis I and five were S. bovis II. Seven biochemical profiles were identified. Pulsed-field gel electrophoresis (PFGE) analysis identified 22 profiles that differed by at least two DNA fragments and showed a similarity of < 87%. Most PFGE patterns represented single isolates that differed in antimicrobial susceptibility, but three PFGE types were observed, with identical profiles and antibiotypes, in isolates from two different patients. S. bovis I and II isolates grouped into two distinct genetic clusters (I and II) with a similarity coefficient of 38%. Two sub-clusters (Ia and Ib), with a similarity coefficient of 47%, included 17 S. bovis I isolates with similar biochemical profiles (15 with biotype A, and two with biotype B), but different resistance phenotypes. Based on the phenotypic and genotypic heterogeneity of the isolates, it is postulated that the increase in S. bovis endocarditis in this geographical area might have been caused by the selection of sporadic endemic clones from the endogenous intestinal flora.


Subject(s)
Bacteremia/microbiology , Endocarditis/microbiology , Streptococcal Infections/epidemiology , Streptococcus bovis/genetics , Bacteremia/diagnosis , Bacteremia/epidemiology , Electrophoresis, Gel, Pulsed-Field , Endocarditis/epidemiology , Genotype , Humans , Italy/epidemiology , Molecular Epidemiology , Streptococcal Infections/complications , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology
12.
J Hosp Infect ; 56(1): 29-36, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14706268

ABSTRACT

We investigated an outbreak of Serratia marcescens in the adult intensive care unit of the University Hospital of Napoli. The outbreak involved 13 cases of infection by S. marcescens over a nine-month period and was caused by a single pulsed-field gel electrophoresis clone. The epidemic strain was multiply antibiotic resistant, producing an inducible Amp C-type beta-lactamase enzyme and carrying the trimethoprim-resistance gene and the adenyltransferase gene, which confers resistance to streptomycin and spectinomycin, within a class 1 integron. Antimicrobial therapy with beta-lactams was associated with S. marcescens acquisition in the intensive care unit.


Subject(s)
Bacterial Proteins , Cross Infection/epidemiology , Disease Outbreaks , Drug Resistance, Multiple, Bacterial/genetics , Serratia Infections/epidemiology , Serratia marcescens/genetics , beta-Lactamases/genetics , Adult , Clone Cells , Cross Infection/genetics , Cross Infection/microbiology , Female , Hospitals, University , Humans , Integrons/genetics , Intensive Care Units , Italy/epidemiology , Male , Serratia Infections/genetics , Serratia Infections/microbiology , Serratia marcescens/enzymology
13.
Br J Cancer ; 88(6): 803-7, 2003 Mar 24.
Article in English | MEDLINE | ID: mdl-12644813

ABSTRACT

In this review, we discuss the available experimental evidences supporting the chemopreventive efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) on colorectal cancer and the biological basis for their possible role as anticancer agents. Although the comprehension of the mechanisms underlying the effects of these drugs on colon cancer cells is incomplete, research efforts in identifying the biochemical pathway by which NSAIDs exert their chemopreventive effect have provided a rationale for the potential use of NSAIDs alone or in combination with conventional and experimental anticancer agents in the treatment of colorectal cancer. In this paper, we review three main issues: (i) the role of COX-2 in colon cancer; (ii) the common death pathways between NSAIDs and anticancer drugs; and (iii) the biological basis for the combination therapy with COX-2 selective inhibitors and new selective inhibitors of growth factor signal transduction pathways.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/prevention & control , Isoenzymes/pharmacology , Prostaglandin-Endoperoxide Synthases/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Apoptosis , Chemoprevention , Combined Modality Therapy , Cyclooxygenase 2 , Growth Substances/pharmacology , Humans , Isoenzymes/antagonists & inhibitors , Membrane Proteins , Signal Transduction
14.
J Hosp Infect ; 52(2): 88-92, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12392899

ABSTRACT

The aim of this investigation was to study the molecular epidemiology of Stenotrophomonas maltophilia in a university hospital in Italy. Sixty-one clinical isolates were collected from 43 patients during a two-year period. The majority of specimens were from the respiratory tract (41 of 43) of patients in the adult intensive care unit (ICU) (19 of 43) or cystic fibrosis (CF) patients (13 of 43). Genotypic analysis by pulsed-field gel electrophoresis (PFGE) of clinical isolates identified 31 different PFGE patterns. Although most patients were infected or colonized by different S. maltophilia clones, clones with identical genotype were isolated in patients from ICU, where two separate outbreaks were identified. Antimicrobial susceptibility identified a multi-resistant phenotype in all S. maltophilia PFGE clones. The majority of PFGE clones identified (six of seven clones from patients in the ICU) were susceptible to fluoroquinolones. Mechanical ventilation was associated with S. maltophilia acquisition in the ICU.


Subject(s)
Cross Infection/epidemiology , Gram-Negative Bacterial Infections/epidemiology , Molecular Epidemiology , Stenotrophomonas maltophilia/isolation & purification , Cross Infection/microbiology , Electrophoresis, Gel, Pulsed-Field , Hospitals, University , Humans , Intensive Care Units , Italy/epidemiology , Microbial Sensitivity Tests , Stenotrophomonas maltophilia/drug effects , Stenotrophomonas maltophilia/genetics
15.
Dig Liver Dis ; 34(7): 498-505, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12236483

ABSTRACT

BACKGROUND: Host response plays a major role in pathogenesis of Helicobacter pylori-induced gastroduodenal disease including adenocarcinoma of distal stomach. Epidermal growth factor-related growth factors are important modulators of gastric homeostasis in normal and damaged gastrointestinal mucosa. AIM: To evaluate expression of heparin binding epidermal growth factor and amphiregulin in antral mucosa of Helicobacter pylori-infected and non-infected dyspeptic patients and to correlate levels of heparin binding-epidermal growth factor and amphiregulin mRNA with mitogenic activity of gastric epithelial cells. METHODS: A total of 10 Helicobacter pylori-infected and 15 Helicobacter pylori non-infected (10 with and 5 without gastritis) dyspeptic patients were studied. Diagnosis of Helicobacter pylori infection was based on rapid urease test and histology. Heparin binding-epidermal growth factor and amphiregulin mRNA expression in antral mucosa were assessed by reverse transcriptase-polymerase chain reaction. Protein expression and localization of both peptides were determined by immunohistochemistry. Mitogenic activity of antral gastric mucosa was assessed by determination of proliferating cell nuclear antigen labelling index by immunohistochemistry. RESULTS: Heparin binding-epidermal growth factor and amphiregulin mRNA expression increased in Helicobacter pylori-infected vs Helicobacter pylori non-infected patients. Heparin binding-epidermal growth factor and amphiregulin immunostaining was more intense and deeper in gastric gland compartment in infected mucosa than in non-infected mucosa. Increase in heparin binding-epidermal growth factor and amphiregulin mRNA expression significantly correlated with increase in proliferating cell nuclear antigen labelling index. CONCLUSIONS: Helicobacter pylori gastritis is associated with up-regulation of heparin binding-epidermal growth factor and amphiregulin which correlates with increased mitogenic activity of gastric mucosa. Increased heparin binding-epidermal growth factor and amphiregulin expression is postulated to contribute to reparative response of gastric mucosa to Helicobacter pylori infection.


Subject(s)
Gastric Mucosa/metabolism , Glycoproteins/physiology , Helicobacter Infections/metabolism , Helicobacter pylori , Intercellular Signaling Peptides and Proteins/physiology , Receptors, Cell Surface/biosynthesis , Up-Regulation/physiology , Adult , Amphiregulin , EGF Family of Proteins , Endoscopy, Gastrointestinal , Female , Gastric Mucosa/pathology , Gastrointestinal Diseases/complications , Gastrointestinal Diseases/metabolism , Glycoproteins/genetics , Growth Substances/metabolism , Helicobacter Infections/complications , Heparin-binding EGF-like Growth Factor , Humans , Immunohistochemistry , Intercellular Signaling Peptides and Proteins/genetics , Male , Middle Aged , RNA, Messenger/biosynthesis , Severity of Illness Index , Statistics as Topic
16.
Br J Cancer ; 86(9): 1501-9, 2002 May 06.
Article in English | MEDLINE | ID: mdl-11986787

ABSTRACT

Numerous studies demonstrate that the chemopreventive effect of non-steroidal anti-inflammatory drugs on colon cancer is mediated through inhibition of cell growth and induction of apoptosis. For these effects non-steroidal anti-inflammatory drugs have been recently employed as sensitising agents in chemotherapy. We have shown previously that treatments with aspirin and NS-398, a cyclo-oxygenase-2 selective inhibitor, affect proliferation, differentiation and apoptosis of the human colon adenocarcinoma Caco-2 cells. In the present study, we have evaluated the effects of aspirin and NS-398 non-steroidal anti-inflammatory drugs on sensitivity of Caco-2 cells to irinotecan (CPT 11) and etoposide (Vp-16) topoisomerase poisons. We find that aspirin co-treatment is able to prevent anticancer drug-induced toxicity, whereas NS-398 co-treatment poorly affects anticancer drug-induced apoptosis. These effects correlate with the different ability of aspirin and NS-398 to interfere with cell cycle during anticancer drug co-treatment. Furthermore, aspirin treatment is associated with an increase in bcl-2 expression, which persists in the presence of the anticancer drugs. Our data indicate that aspirin, but not NS-398, determines a cell cycle arrest associated with death suppression. This provides a plausible mechanism for the inhibition of apoptosis and increase in survival observed in anticancer drug and aspirin co-treatment.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Apoptosis/drug effects , Aspirin/pharmacology , Enzyme Inhibitors/pharmacology , Nitrobenzenes/pharmacology , Sulfonamides/pharmacology , Topoisomerase Inhibitors , Caco-2 Cells , Camptothecin/analogs & derivatives , Camptothecin/pharmacology , Cell Survival , Etoposide/pharmacology , Humans , Irinotecan
18.
Oncogene ; 19(48): 5517-24, 2000 Nov 16.
Article in English | MEDLINE | ID: mdl-11114729

ABSTRACT

Nonsteroidal anti-inflammatory drugs reduce the risk of colon cancer and this effect is mediated in part through inhibition of type 2 prostaglandin endoperoxide synthase/ cyclo-oxygenase (COX-2). In the present study, we demonstrate that COX-2 expression and PGE2 synthesis are up-regulated by an IGF-II/IGF-I receptor autocrine pathway in Caco-2 colon carcinoma cells. COX-2 mRNA and PGE2 levels are higher in proliferating cells compared with post-confluent differentiated cells and in cells that constitutively overexpress IGF-II. Up-regulation of COX-2 expression by IGF-II is mediated through activation of IGF-I receptor because: (i) treatment of Caco-2 cells with a blocking antibody to the IGF-I receptor inhibits COX-2 mRNA expression; (ii) transfection of Caco-2 cells with a dominant negative IGF-I receptor reduces COX-2 expression and activity. Also, the blockade of the PI3-kinase, that mediates the proliferative effect of IGF-I receptor in Caco-2 cells, inhibits IGF-II-dependent COX-2 up-regulation and PGE2 synthesis. Moreover, COX-2 expression and activity inversely correlate with the increase of apoptosis in parental, IGF-II and dominant-negative IGF-I receptor transfected cells. This study suggests that induction of proliferation and tumor progression of colon cancer cells by the IGF-II/IGF-I receptor pathway may depend on the activation of COX-2-related events.


Subject(s)
Caco-2 Cells/metabolism , Dinoprostone/biosynthesis , Insulin-Like Growth Factor II/physiology , Isoenzymes/biosynthesis , Prostaglandin-Endoperoxide Synthases/biosynthesis , RNA, Messenger/biosynthesis , Receptor, IGF Type 1/physiology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antibodies, Monoclonal/pharmacology , Apoptosis/drug effects , Apoptosis/physiology , Caco-2 Cells/enzymology , Cell Division/physiology , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/pharmacology , Disease Progression , Humans , Insulin-Like Growth Factor II/antagonists & inhibitors , Insulin-Like Growth Factor II/biosynthesis , Isoenzymes/genetics , Isoenzymes/metabolism , MAP Kinase Signaling System/physiology , Membrane Proteins , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Nitrobenzenes/pharmacology , Phosphoinositide-3 Kinase Inhibitors , Prostaglandin-Endoperoxide Synthases/genetics , Prostaglandin-Endoperoxide Synthases/metabolism , RNA, Messenger/genetics , Receptor, IGF Type 1/antagonists & inhibitors , Receptor, IGF Type 1/genetics , Signal Transduction/physiology , Sulfonamides/pharmacology , Transfection , Up-Regulation/physiology
19.
J Immunol ; 165(9): 5332-7, 2000 Nov 01.
Article in English | MEDLINE | ID: mdl-11046068

ABSTRACT

Helicobacter pylori (HP)-associated gastritis is characterized by an increased number of acute and chronic inflammatory cells secreting cytokines that contribute to maintain and expand the local inflammation. Locally induced IL-8 is believed to play a major role in the HP-associated acute inflammatory response. Factors/mechanisms that regulate IL-8 induction are, however, not fully understood. In the present study we investigated whether HP infection is associated with an increased production of IL-17, a T cell-derived cytokine capable of modulating IL-8 gene expression. We showed that both IL-17 RNA transcripts and protein were expressed at a higher level in the whole gastric mucosal and lamina propria mononuclear cell samples from HP-infected patients than in those from uninfected subjects. HP: eradication was associated with a marked down-regulation of IL-17 expression. The addition of a neutralizing anti-IL-17 Ab to the gastric lamina propria mononuclear cell cultures resulted in a significant inhibition of IL-8 secretion, indicating that IL-17 contributes to enhance IL-8 in the HP-colonized gastric mucosa. Consistently, stimulation of MKN 28 cells, a gastric epithelial cell line, with IL-17 increased IL-8 secretion. Finally, conditioned medium from the IL-17-stimulated MKN 28 cell cultures promoted the in vitro polymorphonuclear leukocyte migration. This effect was inhibitable by a neutralizing IL-8 but not IL-17 Ab. Together, these data indicate that biologically active IL-17 production is increased during HP: infection, suggesting the possibility that this cytokine may play an important role in the inflammatory response to the HP colonization.


Subject(s)
Gastric Mucosa/immunology , Gastric Mucosa/microbiology , Helicobacter pylori/immunology , Interleukin-17/biosynthesis , Interleukin-8/biosynthesis , Up-Regulation/immunology , Adjuvants, Immunologic/biosynthesis , Adjuvants, Immunologic/physiology , Adult , Aged , Cell Line , Cell-Free System/immunology , Cells, Cultured , Chemotaxis, Leukocyte/immunology , Female , Gastric Mucosa/metabolism , Helicobacter Infections/immunology , Helicobacter Infections/metabolism , Helicobacter Infections/pathology , Humans , Interleukin-17/physiology , Interleukin-8/metabolism , Male , Middle Aged , Neutrophils/immunology
SELECTION OF CITATIONS
SEARCH DETAIL